Center for Molecular Medicine of the Austrian Academy of Sciences

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences is a premier international research institute dedicated to advancing precision medicine through basic and translational biomedical research. Located on the campus of the Medical University of Vienna, CeMM integrates post-genomic technologies—including proteomics, metabolomics, and high-throughput screening—to investigate the molecular basis of cancer, inflammation, and immune disorders. The institute operates with a unique clinical orientation, fostering close collaborations between basic scientists and medical doctors to translate findings into novel therapeutic strategies. CeMM is highly regarded for its innovation ecosystem, having successfully launched several high-profile biotech spin-offs such as Haplogen, Proxygen, and Solgate.